Cost-effectiveness of Stereotactic Body Radiation Therapy versus Video Assisted Thoracic Surgery in medically operable stage I Non-Small Cell Lung Cancer: A modeling study

Stage I Non-Small Cell Lung Cancer (NSCLC) has a relatively good prognosis of 81% (stage IA) or 73% (stage IB) 5-year survival following curative treatments[1]. The most commonly used procedures follow current guidelines, which suggest operable patients should preferably be treated with the appropriate thoracoscopic resection technique with Video Assisted Thoracic Surgery (VATS), while Stereotactic Body Radiation Therapy (SBRT) is preferred in inoperable patients.[2 –4] These guidelines are based on current evidence, although there is disagreement whether there is equipoise for operable patients between SBRT and VATS resection.

Source: Lung Cancer - January 15, 2020 Category: Cancer & Oncology Authors: Henri B. Wolff, Leonie Alberts, Naomi van der Linden, Mathilda L. Bongers, Naomi E. Verstegen, Frank J. Lagerwaard, Frederik N. Hofman, Carin A. Uyl-de Groot, Suresh Senan, Sherif Y. El Sharouni, Elisabeth A. Kastelijn, Franz M.N.H. Schramel, Veerle M.H. Source Type: research